271 related articles for article (PubMed ID: 26798659)
1. Balancing Innate Immunity and Inflammatory State via Modulation of Neutrophil Function: A Novel Strategy to Fight Sepsis.
Fang H; Jiang W; Cheng J; Lu Y; Liu A; Kan L; Dahmen U
J Immunol Res; 2015; 2015():187048. PubMed ID: 26798659
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Ninjurin1 to Toll-like receptor 4 signaling and systemic inflammation.
Jennewein C; Sowa R; Faber AC; Dildey M; von Knethen A; Meybohm P; Scheller B; Dröse S; Zacharowski K
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):656-63. PubMed ID: 25860173
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide-binding protein (LBP) blockade augments the protective effect of granulocyte colony-stimulating factor (G-CSF) in a rat sepsis model.
Liu A; Weiss S; Fang H; Claus RA; Rödel J; Dirsch O; Dahmen U
Shock; 2015 May; 43(5):497-503. PubMed ID: 25874537
[TBL] [Abstract][Full Text] [Related]
4. Innate immune functions of immature neutrophils in patients with sepsis and severe systemic inflammatory response syndrome.
Drifte G; Dunn-Siegrist I; Tissières P; Pugin J
Crit Care Med; 2013 Mar; 41(3):820-32. PubMed ID: 23348516
[TBL] [Abstract][Full Text] [Related]
5.
Takehara M; Seike S; Sonobe Y; Bandou H; Yokoyama S; Takagishi T; Miyamoto K; Kobayashi K; Nagahama M
Commun Biol; 2019; 2():45. PubMed ID: 30729183
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Innate Immunity by G-CSF and Inflammatory Response by LBPK95A Improves the Outcome of Sepsis in a Rat Model.
Fang H; Hua C; Weiss S; Liu A; Cheng W; Claus R; Rödel J; Dirsch O; Dahmen U
J Immunol Res; 2018; 2018():6085095. PubMed ID: 30525057
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony stimulating factor induces lipopolysaccharide (LPS) sensitization via upregulation of LPS binding protein in rat.
Fang H; Liu A; Sun J; Kitz A; Dirsch O; Dahmen U
PLoS One; 2013; 8(2):e56654. PubMed ID: 23437199
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the NF-κB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-α and blocks the septic response in mice.
García JA; Volt H; Venegas C; Doerrier C; Escames G; López LC; Acuña-Castroviejo D
FASEB J; 2015 Sep; 29(9):3863-75. PubMed ID: 26045547
[TBL] [Abstract][Full Text] [Related]
9. New therapeutic targets revealed through investigations of innate immunity.
Ulevitch RJ
Crit Care Med; 2001 Jul; 29(7 Suppl):S8-12. PubMed ID: 11445726
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy.
Holmes CL; Russell JA; Walley KR
Chest; 2003 Sep; 124(3):1103-15. PubMed ID: 12970043
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis.
Weiss M; Moldawer LL; Schneider EM
Blood; 1999 Jan; 93(2):425-39. PubMed ID: 9885204
[No Abstract] [Full Text] [Related]
12. Granulocyte colony-stimulating factor as the expecting sword for the treatment of severe sepsis.
Murata A
Curr Pharm Des; 2003; 9(14):1115-20. PubMed ID: 12769751
[TBL] [Abstract][Full Text] [Related]
13. The chemokine CXCR2 antagonist (AZD5069) preserves neutrophil-mediated host immunity in non-human primates.
Uddin M; Betts C; Robinson I; Malmgren A; Humfrey C
Haematologica; 2017 Feb; 102(2):e65-e68. PubMed ID: 27742769
[No Abstract] [Full Text] [Related]
14. Protective role of surface Toll-like receptor 9 expressing neutrophils in local inflammation during systemic inflammatory response syndrome in mice.
Meng X; Sun W; Ren Y; Xiao Y; Zhao P; Lu W; Hua L; Wang L; Wang L; Yu Y
Mol Immunol; 2017 Oct; 90():74-86. PubMed ID: 28704709
[TBL] [Abstract][Full Text] [Related]
15. Effect of BML-111 on the intestinal mucosal barrier in sepsis and its mechanism of action.
Liu H; Liu Z; Zhao S; Sun C; Yang M
Mol Med Rep; 2015 Aug; 12(2):3101-6. PubMed ID: 25955406
[TBL] [Abstract][Full Text] [Related]
16. Innate immunity in sepsis pathogenesis and its modulation: new immunomodulatory targets revealed.
Kumar V; Sharma A
J Chemother; 2008 Dec; 20(6):672-83. PubMed ID: 19129063
[TBL] [Abstract][Full Text] [Related]
17. Compensatory anti-inflammatory response syndrome.
Adib-Conquy M; Cavaillon JM
Thromb Haemost; 2009 Jan; 101(1):36-47. PubMed ID: 19132187
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
[TBL] [Abstract][Full Text] [Related]
20. A scarlet pimpernel for the resolution of inflammation? The role of supra-therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock.
Wheatley C
Med Hypotheses; 2006; 67(1):124-42. PubMed ID: 16545917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
